Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis

The objective of this case series was to review our experience with pyridostigmine as a treatment for patients with SSc and symptomatic gastrointestinal disease.

Source: Seminars in Arthritis and Rheumatism - January 5, 2018 Category: Rheumatology Authors: Nitin K. Ahuja, Leah Mische, John O. Clarke, Fredrick M. Wigley, Zsuzsanna H. McMahan Source Type: research